written on 02.03.2018

Brazil Pharma Report 2018


With an exit from a period of recession in 2017, a new era of change and positivity is underway in Brazil. Stakeholders from across the public and private sectors are pulling together through strategic partnerships and dialogues to increase both the quantity and quality of the healthcare provided to the 160 million Brazilians who rely on public healthcare as well as the 47 million who are privately insured.


Topics covered in this comprehensive report include the opportunities identified by MNCs in Brazil; regulatory upgrades and shifts in government priorities; the strategies and successes of some of Brazil’s standout domestic companies; as well as briefings from across the value chain in areas as diverse as logistics, plastic surgery and homeopathy.

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here